| For: | Liu T, Wang H, Zhao Y, Wang YX, Xing X, Gao P. Drug development for chronic hepatitis B functional cure: Recent progress. World J Hepatol 2025; 17(4): 105797 [PMID: 40308829 DOI: 10.4254/wjh.v17.i4.105797] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v17/i4/105797.htm |
| Number | Citing Articles |
| 1 |
Yige Wang, Shuhan Tang, Pengyu Li, Yidan Sun, Yaqi Xu, Hao Li, HongYing Xu, Ying Wang, Hailong Zhang, Xianna Li, Zhigang Wang. Untargeted Metabolomic Study of the Anti‐HBV Effects of Erythrocentaurin In Vitro and In Vivo Using UPLC‐Q‐TOF/MS. Biomedical Chromatography 2026; 40(6) doi: 10.1002/bmc.70447
|
| 2 |
Samuel Chima Ugbaja, Reuben Samson Dangana, Idris Olatunji Sanusi, Olukayode Adebola Ibitoye, Asekho Nkungu, Lwandiswa Mafuleka, Moses Okpeku, Nceba Gqaleni. Harnessing artificial intelligence and machine learning for accelerating drug repurposing in hepatitis B virus therapy. Discover Artificial Intelligence 2026; 6(1) doi: 10.1007/s44163-026-01263-7
|
| 3 |
Fatemeh Sana Askari, Alireza Mohebbi. The dynamic states of hepatitis B virus capsid monomers under the impact of different class of capsid-assembly modulators. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-18339-6
|
| 4 |
Liba Sokolovska, Juris Jansons, Franco M. Buonaguro, Maria Isaguliants. Online Conference “Chronic Viral Infections and Cancer, Openings for Vaccines and Cure” VIRCAN2024, Monitoring the Progress. Vaccines 2025; 13(9) doi: 10.3390/vaccines13090940
|
| 5 |
Chao Cui, Yu Sun, Kaiyue Zhang, Jingfei Shi, Kai Wang, Shuai Gao. Research Progress on the Mechanism and Targeted Intervention of G Protein-Coupled Bile Acid Receptor 1 (GPBAR1)-Mediated “Inflammation-Apoptosis-Metabolism-Microcirculation” Regulatory Network in Hepatitis B-Associated Liver Failure. Drug Design, Development and Therapy 2026; doi: 10.2147/DDDT.S573597
|
| 6 |
Maxime Beretta, Ariel Mechaly, Cyril Planchais, Ahmed Haouz, Célia Caillet-Saguy, Nathan Szerman, Yada Aronthippaitoon, Marie-Noëlle Ungeheuer, Stanislas Pol, Catherine Gaudy-Graffin, Camille Sureau, Maryline Bourgine, Hugo Mouquet. In vivo efficacy of combined human broadly neutralizing antibodies against hepatitis B virus. Cell Reports 2025; 44(12) doi: 10.1016/j.celrep.2025.116705
|
| 7 |
Nadezhda A. Pechnikova, Maria Zafeiriou-Chatziefraimidou, Malamati Poimenidou, Chrysi Patsidou, Ioannis Iliadis, Yulia V. Ostankova, Alexey V. Yaremenko. mRNA vaccines for HBV: Mechanisms, preclinical advances, and therapeutic clinical progress. Molecular Therapy Nucleic Acids 2026; 37(1) doi: 10.1016/j.omtn.2025.102819
|
| 8 |
Prashant Tiwari, Istuti Saraswat, Jyoti Gupta. Insight into the Biology of Hepatitis B Virus and Recent Therapeutic Approaches. Current Microbiology 2026; 83(3) doi: 10.1007/s00284-026-04725-4
|
| 9 |
Ayman Elbehiry, Musaad Aldubaib. Hepatocyte-Targeted Drug Delivery Strategies for Chronic Hepatitis B: Overcoming Delivery Barriers Toward Functional Cure. Pharmaceutics 2026; 18(2) doi: 10.3390/pharmaceutics18020212
|
| 10 |
Guangying Wang, Feiyin Chen, Runda Zhao, Zhuoqi Liu, Xiaohong Yang, Daya Luo. Virus-driven remodeling of the immune microenvironment and response to immune checkpoint inhibitors: the infection– immunity–cancer crosstalk. Frontiers in Immunology 2026; 17 doi: 10.3389/fimmu.2026.1807408
|
| 11 |
Yutaka Handa, Ethan Yichen Lee, Yasuhito Tanaka. Toward a Functional Cure for Chronic Hepatitis B: Current Landscape and Future Directions in Japan. Hepatology Research 2026; doi: 10.1111/hepr.70179
|